Medplus Health Services
add_icon

Medplus Health Services

827.75
-6.50
(-0.78%)
Market Cap
9,918.31 Cr
PE Ratio
48.38
Volume
88,327.00
Day High - Low
842.95 - 816.70
52W High-Low
1,045.30 - 678.05
ann
There are new updates from the company12 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
9,918.31 Cr
EPS
12.57
PE Ratio
48.38
PB Ratio
5.43
Book Value
153.68
EBITDA
535.70
Dividend Yield
0.00 %
Industry
Retail
Return on Equity
8.63
Debt to Equity
0.64
Analyst Rating and Forecast
- By Refinitiv from6 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
negative
MedPlus Health Services' subsidiary Optival Health Solutions received a three-day drug license suspension for its Telangana store, resulting in potential revenue loss of Rs 0.60 lacs.
neutral
MedPlus Health Services schedules board meeting for May 29, 2026 to approve Q4FY26 and annual audited financial results. Trading window closed from April 01 to May 31, 2026.
negative
MedPlus Health Services subsidiary Optival Health Solutions receives 3-day drug license suspension for Karnataka store, with potential revenue loss of Rs 0.66 lacs.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
827.75
#1 9,918.31
#3 48.38
#1 6,184.70
#3 9.18
#1 150
#1 25.93
49.04
1,238.30
5,387.96
40.75
5,135.30
30.45
107
14.92
73.53
68.60
133.97
#1 27.17
117.90
#1 99.16
5
-
56.46
55.75
111.13
-
9.20
-4.17
-2
-166.67
47.95

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
9.18 %
Net Income Growth
128.96 %
Cash Flow Change
275.98 %
ROE
107.45 %
ROCE
49.93 %
EBITDA Margin (Avg.)
24.43 %

Quarterly Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
810
810
959
932
941
979
1,004
1,132
1,202
1,267
1,294
1,419
1,451
1,501
1,498
1,588
1,574
1,525
1,558
1,697
1,824
Expenses
743
745
859
863
872
914
941
1,061
1,119
1,171
1,213
1,324
1,350
1,385
1,395
1,452
1,429
1,373
1,412
1,531
1,648
EBITDA
67
65
101
69
69
65
63
71
83
95
81
96
102
116
103
136
145
152
146
166
177
Operating Profit %
7 %
7 %
10 %
7 %
7 %
5 %
5 %
5 %
6 %
7 %
6 %
6 %
6 %
7 %
6 %
8 %
8 %
9 %
8 %
9 %
9 %
Depreciation
22
24
27
28
31
34
38
42
46
56
52
56
57
59
60
63
63
64
66
69
73
Interest
13
15
15
16
17
19
20
20
21
22
23
24
25
25
25
25
26
27
27
29
31
Profit Before Tax
32
26
58
25
22
13
5
9
16
17
5
16
20
32
18
48
57
61
53
69
73
Tax
9
8
12
5
5
1
1
2
3
-9
1
2
6
-2
4
9
11
10
10
13
16
Net Profit
23
18
46
20
17
11
4
7
13
27
4
15
14
34
14
39
46
51
42
56
58
EPS in ₹
2.21
1.76
4.34
1.85
1.53
0.99
0.27
0.55
1.12
2.24
0.32
1.22
1.15
2.81
1.20
3.24
3.84
4.32
3.54
4.63
4.82

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
438
509
538
644
673
1,349
1,566
2,594
2,797
3,005
3,360
Fixed Assets
67
77
81
84
90
420
517
799
1,138
1,242
1,296
Current Assets
317
376
397
458
475
816
923
1,632
1,481
1,568
1,844
Capital Work in Progress
3
4
0
1
1
5
6
20
26
11
16
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
368
429
457
560
582
924
1,043
1,775
1,633
1,752
2,047
Total Equity & Liabilities
438
509
538
644
673
1,349
1,566
2,594
2,797
3,005
3,360
Current Liabilities
210
269
278
326
337
481
415
559
477
526
577
Non Current Liabilities
74
91
111
15
11
339
420
618
830
902
1,044
Total Equity
154
150
149
304
325
529
731
1,417
1,491
1,577
1,740
Reserve & Surplus
141
137
149
303
325
528
359
1,394
1,467
1,554
1,717
Share Capital
12
12
0
0
0
0
0
24
24
24
24

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
32
-15
-10
14
45
56
-37
-93
350
-137
-5
Investing Activities
-16
-32
-15
-18
-19
-28
-35
-703
429
-83
-318
Operating Activities
-19
-17
34
32
147
-7
3
170
90
144
540
Financing Activities
67
35
-29
-1
-83
90
-6
440
-170
-198
-228

Share Holding

% Holding
Aug 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
96.68 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.41 %
40.45 %
40.39 %
40.39 %
40.39 %
40.39 %
40.34 %
40.32 %
40.29 %
40.29 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
12.36 %
0.00 %
14.94 %
14.85 %
14.72 %
15.23 %
15.61 %
16.42 %
16.54 %
16.83 %
DIIs
0.00 %
11.61 %
11.99 %
14.96 %
14.31 %
28.77 %
28.16 %
13.62 %
25.49 %
16.28 %
22.47 %
22.17 %
27.97 %
25.65 %
26.19 %
26.04 %
26.52 %
26.57 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
6.38 %
5.83 %
5.88 %
6.22 %
6.21 %
6.13 %
5.83 %
6.40 %
6.15 %
7.30 %
7.56 %
11.84 %
13.21 %
13.10 %
12.59 %
12.22 %
11.88 %
Others
3.32 %
41.58 %
41.75 %
38.73 %
39.05 %
24.59 %
25.28 %
40.12 %
15.33 %
37.12 %
14.90 %
15.03 %
5.07 %
5.52 %
4.77 %
4.64 %
4.43 %
4.42 %
No of Share Holders
69
3,42,917
82,627
77,119
76,972
74,702
73,512
70,017
66,430
66,048
74,976
76,934
87,328
83,912
83,439
81,742
78,337
79,157

Announcements

Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 201512 hrs ago
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI LODR ")1 day ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20151 day ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report2 days ago
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot2 days ago
Closure of Trading Window4 days ago
Clarification For Delay In Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 20155 days ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20156 days ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20158 days ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 17, 2026
Announcement under Regulation 30 (LODR)-AcquisitionMar 16, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 15, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 14, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 10, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 04, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 26, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 25, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 24, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 23, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 21, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 20, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 13, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 02, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 31, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 30, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 30, 2026
Board Meeting Outcome For Un-Audited Financial Results Of The Company For The Quarter Ended December 31 2025Jan 30, 2026
Board Meeting Outcome for Un-Audited Financial Results Of The Company For The Quarter Ended December 31 2025Jan 30, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jan 30, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 28, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 25, 2026
Intimation Under Regulation 30 Read With Clause 8 Of Para B Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jan 23, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 22, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 20, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 14, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 13, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 11, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 05, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 03, 2026
Board Meeting Intimation for Consider & Approve Un-Audited Financial Result For The Quarter Ended December 31 2025Jan 03, 2026
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 01, 2026
Disclosure Under Regulation 31 Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011Jan 01, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
1.39%
-37300
-0.52%
-0.40%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.03%
2
0.00%
0.00%
Invesco India Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Kotak Business Cycle Fund Direct - Growth
0.00%
0
0.00%
0.00%
Bandhan Aggressive Hybrid Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Balanced Advantage Fund Direct-Growth
0.46%
0
0.00%
0.00%
Bandhan Innovation Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.03%
0
0.00%
0.00%
Bandhan Small Cap Fund Direct-Growth
0.18%
0
0.00%
0.00%
Bajaj Finserv Healthcare Fund Direct-Growth
1.39%
0
0.00%
0.05%
DSP Healthcare Fund Direct - Growth
0.54%
0
0.00%
0.02%
Franklin India ELSS Tax Saver Fund Direct-Growth
0.17%
0
0.00%
0.01%
Franklin India Flexi Cap Fund Direct-Growth
0.59%
0
0.00%
0.00%
Franklin India Multi Asset Allocation Fund Direct-Growth
1.02%
0
0.02%
-0.06%
Franklin India Small Cap Fund Direct-Growth
1.55%
0
0.00%
0.00%
Groww Nifty Total Market Index Fund Direct - Growth
0.03%
0
0.00%
0.00%
HDFC BSE 500 Index Fund Direct - Growth
0.03%
0
0.00%
0.00%
ICICI Prudential Equity & Debt Fund Direct-Growth
0.04%
0
0.00%
0.04%
ICICI Prudential India Opportunities Fund Direct - Growth
0.00%
0
0.00%
0.00%
JM Aggressive Hybrid Fund Direct-Growth
0.00%
0
0.00%
0.00%
Invesco India Contra Fund Direct-Growth
0.47%
0
0.00%
0.03%
Invesco India Large & Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bajaj Finserv Small Cap Fund Direct-Growth
0.62%
0
0.01%
0.01%
Angel One Nifty Total Market Index Fund Direct - Growth
0.03%
0
0.00%
0.00%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
2.54%
0
0.00%
1.09%

Technical Indicators

RSI(14)
Neutral
49.04
ATR(14)
Less Volatile
27.16
STOCH(9,6)
Neutral
37.43
STOCH RSI(14)
Neutral
63.89
MACD(12,26)
Bearish
-0.79
ADX(14)
Weak Trend
11.18
UO(9)
Bearish
47.80
ROC(12)
Downtrend And Accelerating
-0.31
WillR(14)
Neutral
-47.56